In the light of that, our results should be carefully interpreted and therefore reinforce the relevance of the COX-2/PGE2 pathway for tumor thriving and cancer therapy resistance, suggesting it as an interesting target for drug repurposing and new cancer drug development. This evidence concerns the gene PTGS2 and neoplasm.